Infectious diseases are one of the major cases of global morbidity and mortality, resulting in 16.2% of deaths per year (BCC Research, 2016). Infectious diseases are mainly carried through bacteria, viruses or parasites. Bacterial infections lead to the death of approximately 2.5 million people worldwide from bacterial pneumonia, TB and MRSA. Viral diseases, such as HIV, influenza and hepatitis, resulted in 3.1 million deaths worldwide in 2010 (Health, 2013). Delayed diagnosis and treatment have a profound effect on mortality rates and many bacterial and viral diseases present with similar patient symptoms. Hence, there is a clear need for a fast detection system to assist health care professionals correctly diagnose illness. The research performed and ongoing at LIG Biowise will develop a platform for rapid and sensitive diagnostic kit for human and animal pathogens. It is envisaged that this platform of pathogen-specific, antibody-conjugated, biodegradable nanoparticles will become the core technology for future precision treatments of microbial infections.